Literature DB >> 8799700

The cellular and molecular mechanisms of diabetic complications.

G L King1, M Brownlee.   

Abstract

In this article, the cellular and molecular mechanisms of diabetic complications have been reviewed. Hyperglycemia-induced mechanisms that may induce vascular dysfunction in specific sites of diabetic microvascular damage include increased polyol pathway flux, altered cellular redox state, increased formation of diacylglycerol and the subsequent activation of specific PKC isoforms, and accelerated nonenzymatic formation of advanced glycation endproducts. Several of these mechanisms may be responsible for the potentially damaging overproduction of reactive oxygen species observed with hyperglycemia. Each of these mechanisms may contribute to the known pathophysiologic features of diabetic complications by a number of mechanisms, including the upregulation of cytokines and growth factors. Diabetic macrovascular disease may arise more from insulin resistance than from hyperglycemia, and the authors speculate that this may reflect a selective loss of insulin-dependent vascular homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799700     DOI: 10.1016/s0889-8529(05)70324-8

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  42 in total

1.  Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Authors:  Jingjing Zhao; Tao Jiang; Hui Li; Yuejuan Zhang; Nong Zhang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Low doses of vanadate and Trigonella synergistically regulate Na+/K + -ATPase activity and GLUT4 translocation in alloxan-diabetic rats.

Authors:  Mohammad Rizwan Siddiqui; Krishnan Moorthy; Asia Taha; Mohd Ejaz Hussain; Najma Zaheer Baquer
Journal:  Mol Cell Biochem       Date:  2006-04-19       Impact factor: 3.396

3.  BENEFICIAL EFFECTS OF EXOGENOUS CROSSLINKING AGENTS ON SELF-ASSEMBLED TISSUE ENGINEERED CARTILAGE CONSTRUCT BIOMECHANICAL PROPERTIES.

Authors:  Benjamin D Elder; Arvind Mohan; Kyriacos A Athanasiou
Journal:  J Mech Med Biol       Date:  2011-04       Impact factor: 0.897

4.  Cardiovascular complications of diabetes.

Authors:  S Caprio; S Wong; K G Alberti; G King
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

5.  The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitro.

Authors:  Thomas Kunt; Thomas Forst; Christof Kazda; Oliver Harzer; Martin Engelbach; Mirjam Löbig; Jürgen Beyer; Andreas Pfützner
Journal:  J Diabetes Sci Technol       Date:  2007-11

6.  Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.

Authors:  Vanita R Aroda; Baqiyyah N Conway; Stephen J Fernandez; Nathaniel I Matter; John D Maynard; Trevor J Orchard; Robert E Ratner
Journal:  Diabetes Technol Ther       Date:  2013-01-10       Impact factor: 6.118

7.  Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species.

Authors:  Jiazhong Sun; Yancheng Xu; Suxin Sun; Yanlei Sun; Xiang Wang
Journal:  Mol Cell Biochem       Date:  2010-06-04       Impact factor: 3.396

8.  Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects.

Authors:  A Mazza; C Motti; A Nulli; A Pastore; F Andreotti; V Ammaturo; P Bianco; E Santoro; G Federici; C Cortese
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 9.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

10.  Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity.

Authors:  Ju-Young Kim; Dong-Mee Lim; Chan Il Moon; Kyung-Jin Jo; Seong-Kyu Lee; Haing-Woon Baik; Ki-Ho Lee; Kang-Woo Lee; Keun-Young Park; Byung-Joon Kim
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.